If you look at my previous FLXN idea, I called the short from around $20 to $9 using classical charting techniques. I am now calling the bottom on that trade. It looks like a textbook Adam and Eve double bottom. If you analyze the tape a bit more, you can see accumulation going on in the $11-12 dollar range with anything under $11 clearly being bought back up. FLXN has some news in it's pipeline related to Zilretta being submitted to phase 3b testing which will allow it to be repeatedly used for treatment. This should significantly boost sales and they have already been looking good increasing YoY. With their earnings coming out in the next few weeks along with their roadmap being delivered on time I expect shorts to be covered in quick succession. We are approaching the right end of the eve rounded bottom and I marked a few areas of resistance clearly formed on the way down. I expect this stock to recaim it's old range highs and to ultimately set a new ATH within the next 12 months.